Side-by-side comparison of AI visibility scores, market position, and capabilities
Uber (NYSE: UBER) food delivery marketplace with $67B annual delivery gross bookings across 45+ countries; #2 US food platform competing with DoorDash and sharing driver network with ride-hailing for delivery efficiency.
Uber Eats is Uber Technologies' (NYSE: UBER) food delivery marketplace — connecting consumers with restaurant partners for delivery and pickup orders through the Uber Eats app across 6,000+ cities in 45+ countries. Uber's Delivery segment (which includes Uber Eats and Instacart-competitive grocery delivery) generated $17.4 billion in gross bookings in Q4 2024 and $67 billion for fiscal year 2024, making Uber Eats the #2 US food delivery platform behind DoorDash (approximately 67% US market share versus Uber Eats' approximately 23%). Uber Eats serves consumers, restaurants, and delivery couriers simultaneously as a three-sided marketplace.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.